Amicus Therapeutics (FOLD) Operating Income (2016 - 2025)
Historic Operating Income for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $34.3 million.
- Amicus Therapeutics' Operating Income rose 5822.06% to $34.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.8 million, marking a year-over-year increase of 52946.48%. This contributed to the annual value of $24.9 million for FY2024, which is 13221.82% up from last year.
- As of Q3 2025, Amicus Therapeutics' Operating Income stood at $34.3 million, which was up 5822.06% from -$9.5 million recorded in Q2 2025.
- Amicus Therapeutics' Operating Income's 5-year high stood at $34.3 million during Q3 2025, with a 5-year trough of -$75.3 million in Q1 2022.
- Moreover, its 5-year median value for Operating Income was -$27.7 million (2024), whereas its average is -$23.9 million.
- Per our database at Business Quant, Amicus Therapeutics' Operating Income soared by 53258.4% in 2024 and then crashed by 16329.93% in 2025.
- Quarter analysis of 5 years shows Amicus Therapeutics' Operating Income stood at -$72.1 million in 2021, then skyrocketed by 41.33% to -$42.3 million in 2022, then soared by 91.28% to -$3.7 million in 2023, then skyrocketed by 532.58% to $16.0 million in 2024, then surged by 114.57% to $34.3 million in 2025.
- Its Operating Income was $34.3 million in Q3 2025, compared to -$9.5 million in Q2 2025 and -$8.0 million in Q1 2025.